Agenus maintains a world footprint through collaborations and partnerships with main pharmaceutical and biotechnology providers in North The united states, Europe and Asia. Its agreements contain analysis and advancement collaborations, license arrangements and co-development packages geared toward accelerating the translation of novel immunotherap